Published in Br J Clin Pharmacol on February 01, 2000
The effect of staggered administration of zinc sulfate on the pharmacokinetics of oral cephalexin. Br J Clin Pharmacol (2012) 0.75
Effect of Sucralfate on the Relative Bioavailability of Enrofloxacin and Ciprofloxacin in Healthy Fed Dogs. J Vet Intern Med (2015) 0.75
The importance of pharmacokinetic/pharmacodynamic surrogate markers to outcome. Focus on antibacterial agents. Clin Pharmacokinet (1995) 2.66
Effect of ferrous sulfate and multivitamins with zinc on absorption of ciprofloxacin in normal volunteers. Antimicrob Agents Chemother (1989) 1.98
Development and characteristics of sucralfate. J Clin Gastroenterol (1981) 1.76
Sucralfate reduces the gastrointestinal absorption of norfloxacin. Antimicrob Agents Chemother (1989) 1.74
Interactions of aluminum, magnesium, and calcium ions with nalidixic acid. Chem Pharm Bull (Tokyo) (1978) 1.39
Inhibition of norfloxacin absorption by antacids. Antimicrob Agents Chemother (1990) 1.38
Effects of magnesium-aluminum hydroxide and calcium carbonate antacids on bioavailability of ofloxacin. Antimicrob Agents Chemother (1990) 1.28
Urinary excretion of aluminium after ingestion of sucralfate and an aluminium-containing antacid in man. Scand J Gastroenterol (1987) 1.13
Efficacy of sucralfate for duodenal ulcers: a multicenter, double-blind trial. J Clin Gastroenterol (1981) 1.13
Elevation of serum aluminum in humans on a two-day sucralfate regimen. J Clin Pharmacol (1987) 1.12
Pharmacokinetics of quinolones: newer aspects. Eur J Clin Microbiol Infect Dis (1991) 0.98
Drug interactions with quinolones. J Antimicrob Chemother (1990) 0.98
Effects of food and sucralfate on a single oral dose of 500 milligrams of levofloxacin in healthy subjects. Antimicrob Agents Chemother (1997) 0.97
Norfloxacin and absorption of magnesium-aluminum. Ann Intern Med (1988) 0.94
Pharmacokinetics of sparfloxacin and interaction with cisapride and sucralfate. Antimicrob Agents Chemother (1997) 0.88
Effect of staggered dose of calcium on the bioavailability of ciprofloxacin. Antimicrob Agents Chemother (1991) 0.87
Pharmacokinetics of sparfloxacin in humans after single oral administration at doses of 200, 400, 600, and 800 mg. J Clin Pharmacol (1994) 0.86
Drug interactions with fluoroquinolones. Am J Med (1991) 0.85
4-quinolones and multivalent ions. J Antimicrob Chemother (1990) 0.83
Effect of ferrous sulfate on the absorption of sparfloxacin in healthy volunteers and rats. Drugs (1995) 0.79
Determination of sparfloxacin in plasma and urine by a simple and rapid liquid chromatographic method. Ther Drug Monit (1999) 0.79
Comparison of two sucralfate dosages presented in tablet form in duodenal ulcer healing. Am J Med (1987) 0.78
Quinolone pharmacokinetics. Int J Antimicrob Agents (1992) 0.78
The complete genome sequence of the gram-positive bacterium Bacillus subtilis. Nature (1997) 33.47
Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus. Nat Genet (2000) 8.33
Mutations in the hepatocyte nuclear factor-4alpha gene in maturity-onset diabetes of the young (MODY1) Nature (1996) 6.72
Thermodynamic parameters to predict stability of RNA/DNA hybrid duplexes. Biochemistry (1995) 6.40
Mutations in the hepatocyte nuclear factor-1alpha gene in maturity-onset diabetes of the young (MODY3) Nature (1996) 5.32
Improved thermodynamic parameters and helix initiation factor to predict stability of DNA duplexes. Nucleic Acids Res (1996) 5.16
Attenuation of ischemia/reperfusion injury in rats by a caspase inhibitor. Circulation (1998) 3.72
Phase II study of S-1, a novel oral derivative of 5-fluorouracil, in advanced gastric cancer. For the S-1 Cooperative Gastric Cancer Study Group. Oncology (2000) 3.50
Relationship between antimycobacterial activities of rifampicin, rifabutin and KRM-1648 and rpoB mutations of Mycobacterium tuberculosis. J Antimicrob Chemother (1998) 3.41
Prostaglandin D2 selectively induces chemotaxis in T helper type 2 cells, eosinophils, and basophils via seven-transmembrane receptor CRTH2. J Exp Med (2001) 3.23
Localization of inositol 1,4,5-trisphosphate receptor-like protein in plasmalemmal caveolae. J Cell Biol (1992) 2.72
Frequency of a 22q11 deletion in patients with conotruncal cardiac malformations: a prospective study. Eur J Pediatr (1995) 2.66
Species-specific bird functions in a forest-canopy food web. Proc Biol Sci (2000) 2.56
Impact of sarcopenia on survival in patients undergoing living donor liver transplantation. Am J Transplant (2013) 2.51
Tumor promoter, TPA, enhances replication of HTLV-III/LAV. Virology (1986) 2.51
Congenital myasthenic syndrome caused by decreased agonist binding affinity due to a mutation in the acetylcholine receptor epsilon subunit. Neuron (1996) 2.27
Host range of human T-cell leukemia virus type I analyzed by a cell fusion-dependent reporter gene activation assay. Virology (1999) 2.21
Th1/Th2 balance of peripheral T helper cells in systemic lupus erythematosus. Arthritis Rheum (1999) 2.18
SsrA-mediated tagging and proteolysis of LacI and its role in the regulation of lac operon. EMBO J (2000) 2.08
Potent and selective inhibition of human immunodeficiency virus type 1 (HIV-1) by 5-ethyl-6-phenylthiouracil derivatives through their interaction with the HIV-1 reverse transcriptase. Proc Natl Acad Sci U S A (1991) 2.08
The folding type of a protein is relevant to the amino acid composition. J Biochem (1986) 2.07
Patterns of recurrence after initial treatment in patients with small hepatocellular carcinoma. Hepatology (1997) 2.07
Selective expression of a novel surface molecule by human Th2 cells in vivo. J Immunol (1999) 2.07
Induction of cell-membrane porosity by ultrasound. Lancet (1999) 2.06
Tracheobronchial tree: expandable metallic stents used in experimental and clinical applications. Work in progress. Radiology (1986) 2.05
Total cavopulmonary shunt operation in complex cardiac anomalies. A new operation. J Thorac Cardiovasc Surg (1984) 2.01
Mutational analysis of the human immunodeficiency virus type 2 (HIV-2) genome in relation to HIV-1 and simian immunodeficiency virus SIV (AGM). J Virol (1990) 1.99
Rationale for bone marrow transplantation in the treatment of autoimmune diseases. Proc Natl Acad Sci U S A (1985) 1.97
A carbonic anhydrase from the nacreous layer in oyster pearls. Proc Natl Acad Sci U S A (1996) 1.97
Anti-human immunodeficiency virus activity of YK-FH312 (a betulinic acid derivative), a novel compound blocking viral maturation. Antimicrob Agents Chemother (2001) 1.96
Outbreaks of hand, foot, and mouth disease by enterovirus 71. High incidence of complication disorders of central nervous system. Arch Dis Child (1980) 1.96
Low dose intrathecal morphine and pain relief following caesarean section. Int J Obstet Anesth (1994) 1.90
Potent and selective inhibition of human immunodeficiency virus (HIV)-1 and HIV-2 replication by a class of bicyclams interacting with a viral uncoating event. Proc Natl Acad Sci U S A (1992) 1.89
Effects of drift- and benthic-foraging fish on the drift dispersal of three species of mayfly nymphs in a Japanese stream. Oecologia (1999) 1.88
A calpain-10 gene polymorphism is associated with reduced muscle mRNA levels and insulin resistance. J Clin Invest (2000) 1.85
Changes in distribution of hepatic blood flow induced by intra-arterial infusion of angiotensin II in human hepatic cancer. Cancer (1985) 1.84
Establishment of a simple and practical procedure applicable to therapeutic angiogenesis. Circulation (1999) 1.83
Inhibitory effect of 2',3'-didehydro-2',3'-dideoxynucleosides on infectivity, cytopathic effects, and replication of human immunodeficiency virus. Antimicrob Agents Chemother (1987) 1.82
A giant outburst two years before the core-collapse of a massive star. Nature (2007) 1.82
Thermodynamics-structure relationship of single mismatches in RNA/DNA duplexes. Biochemistry (2000) 1.79
T-lymphocyte alveolitis in HTLV-I-associated myelopathy. Lancet (1987) 1.77
The new lead citrate method for the ultracytochemical demonstration of activity of non-specific alkaline phosphatase (orthophosphoric monoester phosphohydrolase). Histochemie (1967) 1.71
Longitudinal evaluation of early Alzheimer's disease using brain perfusion SPECT. J Nucl Med (2000) 1.69
Inhibition of replication and cytopathic effect of human T cell lymphotropic virus type III/lymphadenopathy-associated virus by 3'-azido-3'-deoxythymidine in vitro. Antimicrob Agents Chemother (1986) 1.66
Interleukin-6 and tumor necrosis factor-alpha in patients with obstructive sleep apnea-hypopnea syndrome. Respiration (2004) 1.63
Generation and characterization of the human immunodeficiency virus type 1 mutants. Arch Virol (1991) 1.62
Predominance of Th1 immune response in diffuse proliferative lupus nephritis. Arthritis Rheum (2001) 1.61
Saline-assisted endoscopic resection of rectal carcinoids: cap aspiration method versus simple snare resection. Endoscopy (2004) 1.61
New mutations in acetylcholine receptor subunit genes reveal heterogeneity in the slow-channel congenital myasthenic syndrome. Hum Mol Genet (1996) 1.60
Clinicopathological significance of EZH2 mRNA expression in patients with hepatocellular carcinoma. Br J Cancer (2005) 1.59
CRTH2, an orphan receptor of T-helper-2-cells, is expressed on basophils and eosinophils and responds to mast cell-derived factor(s). FEBS Lett (1999) 1.57
Left ventricular ejection performance, wall stress, and contractile state in aortic regurgitation before and after aortic valve replacement. Circulation (1990) 1.56
Random monoallelic expression of three genes clustered within 60 kb of mouse t complex genomic DNA. Genome Res (2001) 1.56
The mechanism of action of decay-accelerating factor (DAF). DAF inhibits the assembly of C3 convertases by dissociating C2a and Bb. J Exp Med (1987) 1.55
Long-term outcome of adult-to-adult living donor liver transplantation for post-Kasai biliary atresia. Am J Transplant (2006) 1.53
Severity-based treatment for Japanese patients with MPO-ANCA-associated vasculitis: the JMAAV study. Mod Rheumatol (2011) 1.52
Incidence and prevalence of inflammatory bowel disease in Japan: nationwide epidemiological survey during the year 1991. J Gastroenterol (1995) 1.52
Subthalamic nucleus stimulation for Parkinson disease: benefits observed in levodopa-intolerant patients. J Neurosurg (2001) 1.52
Selective activity of several cholic acid derivatives against human immunodeficiency virus replication in vitro. J Acquir Immune Defic Syndr (1989) 1.49
Detection of abnormal cardiac adrenergic neuron activity in adriamycin-induced cardiomyopathy with iodine-125-metaiodobenzylguanidine. J Nucl Med (1992) 1.48
Evaluation of right ventricular function by regional wall motion analysis in patients after correction of tetralogy of Fallot. Comparison of transventricular and nontransventricular repairs. J Thorac Cardiovasc Surg (1992) 1.48
Rapid prediction of rifampin susceptibility of Mycobacterium tuberculosis. Am J Respir Crit Care Med (1997) 1.47
Highly specific inhibition of human immunodeficiency virus type 1 by a novel 6-substituted acyclouridine derivative. Biochem Biophys Res Commun (1989) 1.46
Hepatitis GB virus C genome in the serum of aplastic anaemia patients receiving frequent blood transfusions. Br J Haematol (1997) 1.46
Preparation of antiserum against a tryptic fragment (fragment A) of dynein and an immunological approach to the subunit composition of dynein. J Biol Chem (1975) 1.44
Inhibitory effects of suplatast tosilate on the differentiation and function of monocyte-derived dendritic cells from patients with asthma. Clin Exp Allergy (2007) 1.44
Dynein 2. A new adenosine triphosphatase from sea urchin sperm flagella. J Biol Chem (1976) 1.44
Protective effect of aprotinin on ischemic hepatocellular damage. Transplantation (1989) 1.42
Compton scatter compensation using the triple-energy window method for single- and dual-isotope SPECT. J Nucl Med (1993) 1.42
Ring retractor: a new humeral-head retractor. J Bone Joint Surg Am (1982) 1.41
The use of double-straight needle device in laparoscopic incisional and ventral hernia repair. Surg Laparosc Endosc Percutan Tech (2000) 1.40
Production of anti-cardiolipin antibody in AKR/J mice with streptozocin-induced insulitis and diabetes. Diabetes Res Clin Pract (1993) 1.40
Treatment of renovascular hypertension using stent implantation in an elderly patient with NIDDM. Intern Med (2000) 1.40
Postural tachycardia syndrome in a 28-year-old Japanese woman. Intern Med (2001) 1.39
Relationship of uptake of technetium-99m(Sn)-N-pyridoxyl-5-methyltryptophan by hepatocellular carcinoma to prognosis. J Nucl Med (1991) 1.39
Retreatment of chronic hepatitis C with interferon. Am J Gastroenterol (1994) 1.39
Significance of early measurement of serum hepatitis C virus RNA in predicting response to interferon therapy in patients with chronic hepatitis C. Eur J Gastroenterol Hepatol (1997) 1.39
Growth of the subclavian artery and the anastomosis in Blalock-Taussig shunt: absorbable versus nonabsorbable suture. Ann Thorac Surg (1998) 1.39
Antiproliferative effect of isopentenylated coumarins on several cancer cell lines. Anticancer Res (2001) 1.39
Indocyanine green and fluorescein hyperfluorescence at the site of occlusion in branch retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol (2001) 1.38
Painless thyroiditis occurring during long-term treatment with interferon alfa in a patient with chronic active hepatitis C. South Med J (1996) 1.38
Roles of two VEGF receptors, Flt-1 and KDR, in the signal transduction of VEGF effects in human vascular endothelial cells. Oncogene (2000) 1.38
SIRT2, a tubulin deacetylase, acts to block the entry to chromosome condensation in response to mitotic stress. Oncogene (2006) 1.37
Genome-wide mapping of unselected transcripts from extraembryonic tissue of 7.5-day mouse embryos reveals enrichment in the t-complex and under-representation on the X chromosome. Hum Mol Genet (1998) 1.36
Cutting edge: differential production of prostaglandin D2 by human helper T cell subsets. J Immunol (2000) 1.34
A prospective cohort study on National Health Insurance beneficiaries in Ohsaki, Miyagi Prefecture, Japan: study design, profiles of the subjects and medical cost during the first year. J Epidemiol (1998) 1.33
Inhibitory effect of citrus nobiletin on phorbol ester-induced skin inflammation, oxidative stress, and tumor promotion in mice. Cancer Res (2000) 1.32
Why is the interferon sensitivity-determining region (ISDR) system useful in Japan? J Hepatol (1999) 1.31
A low-molecular-weight inhibitor against the chemokine receptor CXCR4: a strong anti-HIV peptide T140. Biochem Biophys Res Commun (1998) 1.30
Inhibition of human immunodeficiency virus (HIV-1) replication by synthetic oligo-RNA derivatives. Nucleic Acids Res (1989) 1.30
Inhibitory effect of glycyrrhizin on the in vitro infectivity and cytopathic activity of the human immunodeficiency virus [HIV (HTLV-III/LAV)]. Antiviral Res (1987) 1.30
The structure of arthropod hemocyanins. Science (1985) 1.29
Prediction of hemorrhagic complications after thrombolytic therapy for middle cerebral artery occlusion: value of pre- and post-therapeutic computed tomographic findings and angiographic occlusive site. Neurosurgery (1996) 1.28
Assay and Characteristics of Circadian Rhythmicity in Liquid Cultures of Neurospora crassa. Plant Physiol (1981) 1.27
Mutations in the hepatocyte nuclear factor-1alpha gene in MODY and early-onset NIDDM: evidence for a mutational hotspot in exon 4. Diabetes (1997) 1.26
Transient hyperopia with lens swelling at initial therapy in diabetes. Br J Ophthalmol (1993) 1.26
A survey of some Indian medicinal plants for anti-human immunodeficiency virus (HIV) activity. Indian J Med Res (2000) 1.24
Histogenesis of malignant neoplasm induced by adenovirus type 12. Gan (1966) 1.24
Prognostic significance of polo-like kinase expression in esophageal carcinoma. Int J Oncol (1999) 1.24